Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells

Lupus

Volumn 10, Issue 10, 2001, Pages 728-734

  Matera, L ^a   Mori, M ^a   Galetto, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Dendritic cells; Interferon autoimmunity; Monocytes; Prolactin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROLACTIN;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; HUMAN; HYPERPROLACTINEMIA; IMMUNOCOMPETENT CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SYNTHESIS; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, SURFACE; AUTOIMMUNITY; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; MONOCYTES; PROLACTIN; STEM CELLS;

EID: 0034765236     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301717164967     Document Type: Review

References (73)

1. The dendritic cell system and its role in immunogeni city
2. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocute-macrophage colony stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha
3. Dendritic cells and the control of immunity
4. Dendritic cells hold promise for immunotherapy
5. Dendritic cells
6. Molecular and functional characteristics of dendritic cells generated from highly purified CD34+ peripheral blood monocytes
7. Reciprocal control of T helper cell and dendritic cell differentiation
8. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
9. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
10. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate
11. Dendritic cells: From ontogenetic orphans to myelomonocytic descendants
12. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha
13. CDlb restricts the response of human CD4-8-T lymphocytes to a microbial antigen
14. Inhibition of human macrophage colony formation by IL-4
15. CD 14, a receptor for complexes of lypopolysaccharide (LPS) and LPS binding protein
16. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
17. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
18. ÷ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4
19. + peripheral blood monocytes
20. + blood monocytes can differentiate into functionally mature CD83 + dendritic cells
21. Epidermal Langerhans cells are derived from cells originating in bone marrow
22. The Thy-l-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells
23. Antigen processing for amateurs and professionals
24. Granulocytes, macrophages and dendritic cells arise from a common histocompatibility complex class II negative progenitor in mouse bone marrow
25. Dendritic cells and macrophages can mature independently form a human bone marrow-derived post-CFU intermediate
26. Accessory functions and mutual cooperation of murine macrophages and dendritic cells
27. Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides
28. Prostaglandin E and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
29. Pro-inflammatory cytokines and postaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
30. Ligation of CD40 on dendritic cells triggers production of high levels of Interleukin-12 and enhances T cell-stimulatory capacities: T-T help via APC activation
31. T cell-mediated terminal maturation of dendritic cells
32. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production and generation of CTL
33. Dendritic cells produce Interleukin-12 and direct the development of Th1 cells from native CD4+T cells
34. Prolactin and growth hormone in the regulation of the immune system
35. Immune-neuroendocrine interactions
36. Endocrine, paracrine and autocrine actions of prolactin on immune cells
37. Prolactin growth hormone and insulin-like growth factor in the immune system
38. Molecular actions of prolactin in the immune system
39. Prolactin receptors on human T and B lymphocytes
40. Prolactin receptors on large granular lymphocytes: Dual regulation by Cyclosporin A
41. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice
42. Prolactin receptor gene expression in lymphoid cells
43. ÷ve human hemopoietic progenitor cells
44. Bone Marrow stroma-derived prolactin is involved in basal and plateled activating factor-stimulated in vitro erythropoiesis
45. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats
46. Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors
47. AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin
48. Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoral lymphokine-activated killer cells
49. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin
50. Hypophysectomized rats depend on residual prolactin for survival
51. Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients
52. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine
53. Neuroendocrine and reproductive function in male mice with targeted disruption of the prolactin gene
54. Immune system development and function in prolactin receptor-deficient mice
55. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo
56. Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors
57. The prolactin receptor rescues EpoR - / - erythroid progenitors and replaces EpoR in a synergistic interaction with c-kit
58. The prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitors
59. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes
60. Enhanced yield of gamma interferon in prolactin-treated human peripheral blood mononuclear cells
61. Up-modulation of interferon-g mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells
62. Individual and combined effect of GM-CSF and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions
63. Prolactin in autoimmunity and antitumor defence
64. Prolactin regulates anti-tumor immune responses through induction of tumoricidal macro-phages and release of IL-12
65. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortal ity from subsequent sepsis
66. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages
67. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus
68. Induction of autoimmunity with dendritic cells: Studies on thyroiditis in mice
69. Lewis rat lymphoid cells dendritic cells can efficiently present homologous myelin basic protein to encephalito-genic lymphocytes
70. Dendritic cells in cutaneoud lupus erythematosus: A clue to the pathogenesis of lesions
71. Functional deficiencies of spleen dendritic cells in autoimmune MRL/1pr mice
72. Examination of the mononuclear phagocyte system in lupus-prone male BXSB mice
73. The dysfunction of human peripheral blood dendritic cells on Concanavalin A-induced T cell responses in patients with systemic lupus erythematosus